NASDAQ:WBA - Walgreens Boots Alliance Stock Price, Price Target & More

Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."

Walgreens Boots Alliance declared a quarterly dividend on Friday, June 29th. Shareholders of record on Monday, August 20th will be paid a dividend of $0.44 per share on Wednesday, September 12th. This represents a $1.76 dividend on an annualized basis and a yield of 2.71%. The ex-dividend date of this dividend is Friday, August 17th. This is a boost from Walgreens Boots Alliance's previous quarterly dividend of $0.40. View Walgreens Boots Alliance's Dividend History.

Walgreens Boots Alliance announced that its Board of Directors has authorized a stock repurchase program on Thursday, October 26th 2017, which authorizes the company to repurchase $1,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to purchase shares of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's management believes its stock is undervalued.

Walgreens Boots Alliance Inc (NASDAQ:WBA) released its earnings results on Thursday, June, 28th. The pharmacy operator reported $1.53 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.47 by $0.06. The pharmacy operator had revenue of $34.33 billion for the quarter, compared to the consensus estimate of $34.15 billion. Walgreens Boots Alliance had a net margin of 3.36% and a return on equity of 21.22%. The firm's revenue was up 14.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.33 earnings per share. View Walgreens Boots Alliance's Earnings History.

Walgreens Boots Alliance updated its FY18 earnings guidance on Thursday, June, 28th. The company provided earnings per share (EPS) guidance of $5.90-6.05 for the period, compared to the Thomson Reuters consensus estimate of $5.95.

18 brokerages have issued 1-year price objectives for Walgreens Boots Alliance's shares. Their forecasts range from $60.00 to $96.00. On average, they expect Walgreens Boots Alliance's share price to reach $77.0588 in the next year. This suggests a possible upside of 18.6% from the stock's current price. View Analyst Ratings for Walgreens Boots Alliance.

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last year. There are currently 1 sell rating, 11 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Walgreens Boots Alliance saw a increase in short interest in June. As of June 15th, there was short interest totalling 17,165,556 shares, an increase of 15.9% from the May 31st total of 14,810,457 shares. Based on an average trading volume of 5,380,135 shares, the short-interest ratio is currently 3.2 days. Approximately 2.0% of the company's stock are sold short. View Walgreens Boots Alliance's Current Options Chain.

Some companies that are related to Walgreens Boots Alliance include CVS Health (CVS), Express Scripts (ESRX), Rite Aid (RAD), Diplomat Pharmacy (DPLO), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Media stories about WBA stock have been trending somewhat negative this week, according to Accern Sentiment. The research firm identifies positive and negative press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Walgreens Boots Alliance earned a daily sentiment score of -0.05 on Accern's scale. They also gave media headlines about the pharmacy operator an impact score of 43.98 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

Walgreens Boots Alliance's stock is owned by many different of retail and institutional investors. Top institutional investors include Bank of Montreal Can (0.17%), Hexavest Inc. (0.14%), Assenagon Asset Management S.A. (0.10%), Retirement Systems of Alabama (0.08%), Gateway Investment Advisers LLC (0.07%) and Boston Advisors LLC (0.05%). Company insiders that own Walgreens Boots Alliance stock include Janice M Babiak, John Anthony Lederer, Kathleen Wilson-Thompson, Ornella Barra, Stefano Pessina and William C Foote. View Institutional Ownership Trends for Walgreens Boots Alliance.

WBA stock was sold by a variety of institutional investors in the last quarter, including Hartford Investment Management Co., Benjamin F. Edwards & Company Inc., Welch & Forbes LLC, Guidant Wealth Advisors, Grassi Investment Management, Municipal Employees Retirement System of Michigan, Gofen & Glossberg LLC IL and Jacobs & Co. CA. View Insider Buying and Selling for Walgreens Boots Alliance.

WBA stock was purchased by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Boston Advisors LLC, Retirement Systems of Alabama, Bank of Montreal Can, RNC Capital Management LLC, Cornerstone Wealth Management LLC, DnB Asset Management AS and Manning & Napier Group LLC. Company insiders that have bought Walgreens Boots Alliance stock in the last two years include Janice M Babiak, John Anthony Lederer, Ornella Barra and Stefano Pessina. View Insider Buying and Selling for Walgreens Boots Alliance.

Shares of WBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of WBA stock can currently be purchased for approximately $64.98.

Walgreens Boots Alliance has a market capitalization of $64.44 billion and generates $118.21 billion in revenue each year. The pharmacy operator earns $4.08 billion in net income (profit) each year or $5.10 on an earnings per share basis. Walgreens Boots Alliance employs 345,000 workers across the globe.

Walgreens Boots Alliance's mailing address is 108 Wilmot Road, Deerfield IL, 60015. The pharmacy operator can be reached via phone at 847-315-2500 or via email at [email protected]